Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
The Global Telemedicine Market will grow by USD 56.47 bn during 2020-2024
Goldman Sachs Group Inc. Sells 63,245 Shares of BioTelemetry Inc (NASDAQ:BEAT)
04:50am, Thursday, 17'th Sep 2020
Goldman Sachs Group Inc. lessened its holdings in shares of BioTelemetry Inc (NASDAQ:BEAT) by 29.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 150,633
Should You Investigate BioTelemetry, Inc. (NASDAQ:BEAT) At US$42.02?
02:13pm, Friday, 07'th Aug 2020
BioTelemetry, Inc. (NASDAQ:BEAT), is not the largest company out there, but it received a lot of attention from a...
$106.67 Million in Sales Expected for BioTelemetry Inc (NASDAQ:BEAT) This Quarter
01:50am, Wednesday, 05'th Aug 2020
Wall Street brokerages forecast that BioTelemetry Inc (NASDAQ:BEAT) will post sales of $106.67 million for the current quarter, Zacks reports. Two analysts have provided estimates for BioTelemetry’s
BioTelemetry Inc (BEAT) Q2 2020 Earnings Call Transcript
07:01am, Friday, 31'st Jul 2020
Ladies and gentlemen, good afternoon, and thank you for joining us for the BioTelemetry Second Quarter 2020 Earnings Conference Call. Such statements involve known and unknown risks, uncertainties an
BioTelemetry (BEAT) Beats Q2 Earnings and Revenue Estimates
11:50pm, Thursday, 30'th Jul 2020
BioTelemetry (BEAT) delivered earnings and revenue surprises of 191.67% and 15.34%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BioTelemetry's (BEAT) CEO Joseph Capper on Q2 2020 Results - Earnings Call Transcript
11:19pm, Thursday, 30'th Jul 2020
BioTelemetry, Inc. (NASDAQ:BEAT) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial
BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
08:05pm, Thursday, 30'th Jul 2020
Posts Strong Results and Ramps Up Business Development ActivityMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused o
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation
11:00am, Thursday, 30'th Jul 2020
Company expands portfolio of solutions with groundbreaking insertable cardiac monitor systemMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
BioTelemetry, Inc. Acquires Remote Patient Monitoring Platform from Centene Subsidiary
12:00pm, Wednesday, 29'th Jul 2020
Expands relationship to serve Centene membersMALVERN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
BioTelemetry, Inc. to Release Second Quarter 2020 Earnings Results on July 30, 2020
08:05pm, Thursday, 23'rd Jul 2020
MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly
10,802 Shares in BioTelemetry Inc (NASDAQ:BEAT) Purchased by Advisor Group Holdings Inc.
08:26pm, Thursday, 16'th Jul 2020
Advisor Group Holdings Inc. acquired a new position in BioTelemetry Inc (NASDAQ:BEAT) during the 1st quarter, according to its most recent filing with the SEC. The fund acquired 10,802 shares of the m
